After obtaining informed consent , positioning , and baseline EPs recording , patients were randomly assigned to either IV dexmedetomidine 0.6 g/kg infused over 10 minutes , followed by 0.6 g/kg/h , or a corresponding volume of IV normal saline ( placebo ) .